(Q33882008)

English

Inhibition of eosinophil activation in bronchoalveolar lavage fluid from atopic asthmatics by Y-24180, an antagonist to platelet-activating factor

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Inhibition of eosinophil activation in bronchoalveolar lavage fluid from atopic asthmatics by Y-24180, an antagonist to platelet-activating factor (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

0 references

bronchoalveolar lavage

1 reference

based on heuristic

inferred from title

author name string

Mizuki M

1

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Komatsu H

2

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Akiyama Y

3

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Iwane S

4

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Tsuda T

5

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

language of work or name

0 references

publication date

1 January 1999

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

65

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

20

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

2031-2039

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Leukocyte-dependent histamine release from rabbit platelets. The role of IgE, basophils, and a platelet-activating factor

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900470-1

7 January 2021

Effects of inhaled platelet activating factor on pulmonary function and bronchial responsiveness in man

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900470-1

7 January 2021

Effect of platelet-activating factor on airway vascular permeability: possible mechanisms.

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900470-1

7 January 2021

Eosinophil recruitment into guinea pig lungs after PAF-acether and allergen administration. Modulation by prostacyclin, platelet depletion, and selective antagonists.

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900470-1

7 January 2021

Platelet-activating factor as a mediator of allergic disease

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900470-1

7 January 2021

Pharmacological actions of Y-24180, a new specific antagonist of platelet activating factor (PAF): II. Interactions with PAF and benzodiazepine receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900470-1

7 January 2021

Pharmacological actions of Y-24180: I. A potent and specific antagonist of platelet-activating factor

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900470-1

7 January 2021

Effect of Y-24180, a long-acting antagonist to platelet-activating factor (PAF), on PAF-induced reactions: a relationship between the partial structure of the compound and its duration of the action

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900470-1

7 January 2021

Effects of Y-24180, a long-acting and potent antagonist to platelet-activating factor, on immediate asthmatic response in guinea pigs

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900470-1

7 January 2021

Suppressive effects of Y-24180, a receptor antagonist to platelet activating factor (PAF), on antigen-induced asthmatic responses in guinea pigs

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900470-1

7 January 2021

Suppressive effects of Y-24180, a long-acting antagonist for platelet-activating factor, on allergic pulmonary eosinophilia in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900470-1

7 January 2021

Effects of a PAF antagonist, Y-24180, on bronchial hyperresponsiveness in patients with asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900470-1

7 January 2021

Direct-writing recorder of the dose-response curves of the airway to methacholine. Clinical application.

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900470-1

7 January 2021

Platelet-activating factor. A potent chemotactic and chemokinetic factor for human eosinophils.

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900470-1

7 January 2021

Selective regulation of expression of surface adhesion molecules Mac-1, L-selectin, and VLA-4 on human eosinophils and neutrophils

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900470-1

7 January 2021

Inhibition of leukocyte adhesion to endothelial cells of human umbilical vein by Y-24180, an antagonist of platelet-activating factor

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900470-1

7 January 2021

Inhibition of Mac-1-dependent leukocyte adhesion by Y-24180, an anti-inflammatory agent, in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900470-1

7 January 2021

Identifiers

10.1016/S0024-3205(99)00470-1

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33882008&oldid=1534588845"